LumineticsCore
Commercial- Indications
- Diabetic retinopathy, Diabetic macular edema
Company intelligence / Profile preview
Digital Diagnostics developed the first FDA-cleared autonomous AI system capable of diagnosing diabetic retinopathy and diabetic macular edema at the point-of-care without physician input. Clinical trials demonstrated safety and efficacy in primary care settings. The company continues to expand its platform to cover additional diseases but has not disclosed clinical results or stages for these pipeline programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Digital Diagnostics.